Semglee

Active Ingredient(s): Insulin Glargine
FDA Approved: * June 11, 2020
Pharm Company: * MYLAN PHARMS INC
Category: Diabetes

Insulin glargine [GLAR geen], sold under the brand name Lantus among others, is a long-acting insulin, used in the management of type I and type II diabetes.[6] It is typically the recommended long acting insulin in the United Kingdom.[7][contradictory] It is used once a day as an injection just under the skin.[6] Effects generally begin an hour after use.[6] Common side effects include low blood sugar, problems a... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Semglee 100 [Iu]/Ml Subcutaneous Injection, Solution
NDC: 49502-195
Labeler:
Mylan Specialty L.p.
Semglee 100 [Iu]/Ml Subcutaneous Injection, Solution
NDC: 49502-196
Labeler:
Mylan Specialty L.p.
Semglee 100 [Iu]/Ml Subcutaneous Injection, Solution
NDC: 49502-250
Labeler:
Mylan Specialty L.p.
Semglee 100 [Iu]/Ml Subcutaneous Injection, Solution
NDC: 49502-251
Labeler:
Mylan Specialty L.p.
Semglee 100 [Iu]/Ml Subcutaneous Injection, Solution
NDC: 50090-5835
Labeler:
A-s Medication Solutions

Related Brands

Drugs with the same active ingredients